The Economics of Drug Development in 2022 On 8 October, 2012, in celebration of its 50th anniversary, OHE will be holding an important conference to consider what drug development may look like ten years hence, in 2022. The conference will be held in London on Monday, 8 October 2012.
The Economics of Drug Development in 2022 On 8 October, 2012, in celebration of its 50th anniversary, OHE will be holding an important conference to consider what drug development may look like ten years hence, in 2022. Confirmed speakers to date include:
- Dr Richard Barker, Director of the Centre for Accelerating Medical Innovations, University of Oxford
- Professor Sir Alasdair Breckenridge, Chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA)
- Professor Patricia Danzon, The Wharton School, University of Pennsylvania
- Dr Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency
- Dr Jens Grueger, Head, Global Health Economics and Pricing, Roche Pharmaceuticals
- Dr Hannah Kettler, Senior Program Officer and Economist, The Bill & Melinda Gates Foundation
- Professor Fabio Pammolli, Professor of Economics and Management, IMT Institute For Advanced Studies
- Professor Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence (NICE)
The conference will be held in London on Monday, 8 October 2012, from 10.00 AM to 6.00 PM, with a drinks reception to follow.
Registration details and a full conference agenda will be posted soon on the website and OHE News.
